Longitudinal magnetic resonance imaging in progressive supranuclear palsy: A new combined score for clinical trials
ConclusionsWe propose the 1‐year change in the volumes of third ventricle, midbrain, and frontal lobe as combined imaging read‐out for clinical trials in PSP that require the least number of patients for detecting efficacy to reduce brain atrophy. © 2017 International Parkinson and Movement Disorder Society
Source: Movement Disorders - Category: Neurology Authors: G ünter U. Höglinger, Jakob Schöpe, Maria Stamelou, Jan Kassubek, Teodoro del Ser, Adam L. Boxer, Stefan Wagenpfeil, Hans‐Jürgen Huppertz, , , Tags: Research Article Source Type: research
More News: Brain | Clinical Trials | MRI Scan | Neurology | Parkinson's Disease | Progressive Supranuclear Palsy | Study